{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:49:32Z","timestamp":1792637372406,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"am","delay-in-days":325,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-22-055-01-IBCD"],"award-info":[{"award-number":["RSG-22-055-01-IBCD"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI168684"],"award-info":[{"award-number":["R01AI168684"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA286122"],"award-info":[{"award-number":["R01CA286122"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA046592"],"award-info":[{"award-number":["P30 CA046592"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM143014"],"award-info":[{"award-number":["R35GM143014"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R43CA287530"],"award-info":[{"award-number":["R43CA287530"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA266981"],"award-info":[{"award-number":["R01CA266981"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017065","name":"Rogel Cancer Center, University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jconrel.2025.113617","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T03:54:10Z","timestamp":1742183650000},"page":"113617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Investigation of the impact of lipid nanoparticle compositions on the delivery and T cell response of circRNA vaccine"],"prefix":"10.1016","volume":"381","author":[{"given":"Yasir","family":"Alshehry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2025.113617_bb0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.jconrel.2025.113617_bb0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113617_bb0015","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical Progress of mRNA vaccines and immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113617_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1384","article-title":"mRNA vaccine in cancer therapy: current advance and future outlook","volume":"13","author":"Li","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.113617_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069761","article-title":"Clinical severity of, and effectiveness of mRNA vaccines against, Covid-19 from omicron, Delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study","volume":"376","author":"Lauring","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.jconrel.2025.113617_bb0030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2022.05.043","article-title":"Circular RNA: an emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines","volume":"348","author":"Liu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113617_bb0035","doi-asserted-by":"crossref","unstructured":"Huff, A. L.; Jaffee, E. M.; Zaidi, N. Messenger RNA vaccines for cancer immunotherapy: progress promotes promise. J. Clin. Invest.. 132 (6), e156211.","DOI":"10.1172\/JCI156211"},{"issue":"4","key":"10.1016\/j.jconrel.2025.113617_bb0040","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.113617_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113617_bb0050","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.113617_bb0055","article-title":"Lipid nanoparticles in the development of mRNA vaccines for COVID-19","volume":"74","author":"Wilson","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113617_bb0060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s40005-022-00569-9","article-title":"Recent advancements in lipid\u2013mRNA nanoparticles as a treatment option for Cancer immunotherapy","volume":"52","author":"Karmacharya","year":"2022","journal-title":"J. Pharm. Investig."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113617_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"27","key":"10.1016\/j.jconrel.2025.113617_bb0070","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113617_bb0075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113617_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"34","key":"10.1016\/j.jconrel.2025.113617_bb0085","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207841119","article-title":"Lipid nanoparticle-mediated lymph node\u2013targeting delivery of mRNA Cancer vaccine elicits robust CD8+ T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113617_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10213","article-title":"Cytosolic delivery of nucleic acids: the case of Ionizable lipid nanoparticles","volume":"6","author":"Schlich","year":"2021","journal-title":"Bioeng. Transl. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113617_bb0095","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tips.2021.03.002","article-title":"The importance of apparent pKa in the development of nanoparticles encapsulating siRNA and mRNA","volume":"42","author":"Patel","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113617_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/natrevmats.2017.56","article-title":"Tools for translation: non-viral materials for therapeutic mRNA delivery","volume":"2","author":"Hajj","year":"2017","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.113617_bb0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2020.12.014","article-title":"Self-assembled mRNA vaccines","volume":"170","author":"Kim","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113617_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113617_bb0115","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","article-title":"A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human Primates","volume":"26","author":"Sabnis","year":"2018","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113617_bb0120","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.nano.2016.12.014","article-title":"Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA","volume":"13","author":"Kulkarni","year":"2017","journal-title":"Nanomedicine"},{"issue":"8","key":"10.1016\/j.jconrel.2025.113617_bb0125","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/bi950414i","article-title":"Influence of cholesterol on the Association of Plasma Proteins with liposomes","volume":"35","author":"Semple","year":"1996","journal-title":"Biochemistry"},{"issue":"42","key":"10.1016\/j.jconrel.2025.113617_bb0130","doi-asserted-by":"crossref","first-page":"E9944","DOI":"10.1073\/pnas.1811276115","article-title":"High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing","volume":"115","author":"Sago","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113617_bb0135","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1021\/bi952000v","article-title":"Poly(Ethylene Glycol)--lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine","volume":"35","author":"Holland","year":"1996","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.jconrel.2025.113617_bb0140","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1039\/c3nr05559k","article-title":"Effect of Polyethyleneglycol (PEG) chain length on the bio-Nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells","volume":"6","author":"Pozzi","year":"2014","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113617_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11095-022-03166-5","article-title":"Biodistribution and non-linear gene expression of mRNA LNPs affected by delivery route and particle size","volume":"39","author":"Di","year":"2022","journal-title":"Pharm. Res."},{"issue":"21","key":"10.1016\/j.jconrel.2025.113617_bb0150","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1021\/acs.accounts.1c00500","article-title":"Developing biodegradable lipid nanoparticles for intracellular mRNA delivery and genome editing","volume":"54","author":"Qiu","year":"2021","journal-title":"Acc. Chem. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113617_bb0155","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1039\/D1NR06858J","article-title":"Development of a high-throughput platform for screening lipid nanoparticles for mRNA delivery","volume":"14","author":"Cui","year":"2022","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2025.113617_bb0160","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jconrel.2019.10.028","article-title":"Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening","volume":"316","author":"Guimaraes","year":"2019","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.jconrel.2025.113617_bb0165","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"issue":"9","key":"10.1016\/j.jconrel.2025.113617_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239369","article-title":"Chitosan nanoparticles as antigen vehicles to induce effective tumor specific T cell responses","volume":"15","author":"Walter","year":"2020","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.jconrel.2025.113617_bb0175","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3390\/ph15081017","article-title":"mRNA-loaded lipid nanoparticles targeting immune cells in the spleen for use as Cancer vaccines","volume":"15","author":"Shimosakai","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"8","key":"10.1016\/j.jconrel.2025.113617_bb0180","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3390\/pharmaceutics14081572","article-title":"mRNA-loaded lipid nanoparticles targeting dendritic cells for Cancer immunotherapy","volume":"14","author":"Sasaki","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113617_bb0185","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.omtn.2022.09.017","article-title":"Design and Lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman Primates","volume":"30","author":"Suzuki","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2025.113617_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106234","article-title":"Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways","volume":"176","author":"Tam","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.jconrel.2025.113617_bb0195","doi-asserted-by":"crossref","first-page":"10481","DOI":"10.1021\/acsami.8b21398","article-title":"Lipid-mRNA nanoparticle designed to enhance intracellular delivery mediated by shock waves","volume":"11","author":"Zhang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.113617_bb0200","article-title":"Testing the in vitro and in vivo efficiency of mRNA-lipid nanoparticles formulated by microfluidic mixing","volume":"191","author":"El-Mayta","year":"2023","journal-title":"J. Vis. Exp. JoVE"},{"issue":"11","key":"10.1016\/j.jconrel.2025.113617_bb0205","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.ymthe.2019.07.018","article-title":"Endocytic profiling of Cancer cell models reveals critical factors influencing LNP-mediated mRNA delivery and protein expression","volume":"27","author":"Sayers","year":"2019","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"issue":"7","key":"10.1016\/j.jconrel.2025.113617_bb0210","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1021\/acs.molpharmaceut.2c00033","article-title":"Comparison of DLin-MC3-DMA and ALC-0315 for siRNA delivery to hepatocytes and hepatic stellate cells","volume":"19","author":"Ferraresso","year":"2022","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113617_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10580","article-title":"Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles","volume":"8","author":"Lewis","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.113617_bb0220","first-page":"125","article-title":"Lipid nanoparticle composition drives mRNA delivery to the placenta","volume":"34","author":"Young","year":"2024","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113617_bb0225","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41467-020-14527-2","article-title":"Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA","volume":"11","author":"Patel","year":"2020","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.jconrel.2025.113617_bb0230","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1720542115","article-title":"Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles","volume":"115","author":"Yanez Arteta","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.jconrel.2025.113617_bb0235","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.113617_bb0240","article-title":"Mass production system for RNA-loaded lipid nanoparticles using piling up microfluidic devices","volume":"31","author":"Maeki","year":"2023","journal-title":"Appl. Mater. Today"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113617_bb0245","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-022-31993-y","article-title":"Multi-step screening of DNA\/lipid nanoparticles and co-delivery with siRNA to enhance and prolong gene expression","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113617_bb0250","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202110137","article-title":"Endosomal escape of delivered mRNA from endosomal recycling tubules visualized at the nanoscale","volume":"221","author":"Paramasivam","year":"2021","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113617_bb0255","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40035-015-0041-1","article-title":"The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration","volume":"4","author":"Hu","year":"2015","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113617_bb0260","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","article-title":"An Ionizable lipid toolbox for RNA delivery","volume":"12","author":"Han","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jconrel.2025.113617_bb0265","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.jconrel.2025.113617_bb0270","series-title":"Cancer Metastasis And The Lymphovascular System: Basis For Rational Therapy, Cancer Treatment and Research","first-page":"223","article-title":"Significance of regional draining lymph nodes in the development of tumor immunity: implications for cancer immunotherapy","author":"Zheng","year":"2007"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113617_bb0275","doi-asserted-by":"crossref","DOI":"10.1063\/5.0073494","article-title":"Performance of nanoparticles for biomedical applications: the in vitro\/in vivo discrepancy","volume":"3","author":"Berger","year":"2022","journal-title":"Biophys. Rev."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113617_bb0280","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1021\/acsinfecdis.8b00111","article-title":"Lymph nodes: the unrecognized barrier against pathogens","volume":"4","author":"Bogoslowski","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.113617_bb0285","first-page":"1","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113617_bb0290","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41563-020-00886-0","article-title":"Membrane-destabilizing Ionizable phospholipids for organ-selective mRNA delivery and CRISPR\u2013Cas gene editing","volume":"20","author":"Liu","year":"2021","journal-title":"Nat. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113617_bb0295","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1039\/D1BM01454D","article-title":"Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA)","volume":"10","author":"\u00c1lvarez-Benedicto","year":"2022","journal-title":"Biomater. Sci."},{"issue":"14","key":"10.1016\/j.jconrel.2025.113617_bb0300","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.3390\/nano12142446","article-title":"In Cellulo and in vivo comparison of cholesterol, beta-sitosterol and dioleylphosphatidylethanolamine for lipid nanoparticle formulation of mRNA","volume":"12","author":"Medjmedj","year":"2022","journal-title":"Nanomaterials"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113617_bb0305","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1021\/acs.nanolett.0c01386","article-title":"Deconvoluting lipid nanoparticle structure for messenger RNA delivery","volume":"20","author":"Eygeris","year":"2020","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113617_bb0310","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0005-2760(95)00053-F","article-title":"Side-chain structure is critical for the transport of sterols from lysosomes to cytoplasm","volume":"1257","author":"Sato","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"issue":"40","key":"10.1016\/j.jconrel.2025.113617_bb0315","doi-asserted-by":"crossref","first-page":"15223","DOI":"10.1073\/pnas.0808256105","article-title":"NPC1\/NPC2 function as a tag team duo to mobilize cholesterol","volume":"105","author":"Subramanian","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2025.113617_bb0320","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.2614","article-title":"Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling","volume":"31","author":"Sahay","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"41","key":"10.1016\/j.jconrel.2025.113617_bb0325","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1021\/acs.jafc.8b04555","article-title":"Identification of \u03b2-Sitosterol as in vitro anti-inflammatory constituent in Moringa Oleifera","volume":"66","author":"Liao","year":"2018","journal-title":"J. Agric. Food Chem."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113617_bb0330","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.advnut.2023.05.013","article-title":"\u03b2-Sitosterol as a promising anticancer agent for chemoprevention and chemotherapy: mechanisms of action and future prospects","volume":"14","author":"Wang","year":"2023","journal-title":"Adv. Nutr."},{"issue":"9","key":"10.1016\/j.jconrel.2025.113617_bb0335","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3390\/vaccines9091007","article-title":"Development of an mRNA-LNP vaccine against SARS-CoV-2: evaluation of immune response in mouse and Rhesus macaque","volume":"9","author":"Naderi Sohi","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2025.113617_bb0340","article-title":"Ethanol injection technique for liposomes formulation: an insight into development, influencing factors, challenges and applications","volume":"61","author":"Gouda","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925002342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925002342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:08:24Z","timestamp":1778674104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925002342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":68,"alternative-id":["S0168365925002342"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113617","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the impact of lipid nanoparticle compositions on the delivery and T cell response of circRNA vaccine","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113617"}}